Sunday, 14 August 2022

 

 

LATEST NEWS Since 1917, Jharkhand's Tana Bhagats have been worshipping the Tricolour daily One thing that stands out is how Rohit Sharma backs players who aren't performing: Parthiv Patel Since 1917, Jharkhand's Tana Bhagats have been worshipping the Tricolour daily This drug can fight more than 300 drug-resistant bacteria Madonna Sebastian to appear opposite Tovino Thomas in 'Identity' Australia plans to increase migrant intake amid skill crisis A Rajasthan Royals owner slapped me three or four times, says Ross Taylor in his autobiography PM pays homage to all those who lost their lives during Partition Saumya Tandon urges fans to help late 'Bhabiji' star Deepesh Bhan's family repay loan No Olympic future for CWG lawn bowls 'trailblazers', squash players Honour freedom fighters by flying the National Flag, says Rajinikanth Vijay Sethupathi's team clarifies: Actor not a part of 'Pushpa 2' AAP's expanding its national presence at a rapid pace after Punjab victory Birmingham 2022 successes could mark the start of a new era in Indian athletics Simona Halep moves into Toronto final; set to enter Top-10 in latest WTA rankings For wife Mila Kunis, Ashton Kutcher with moustache was 'like a different guy' TOPS has given a different 'spin' to sports in India, says Mansher Singh India's Covid tally declines to 14,092 cases, 41 deaths 13 killed, 5 injured as truck falls over bus in Pakistan Elon Musk hopes for a self-sustaining city on Mars in 20 years Musk pitches lofty goals in magazine run by China's Internet censorship agency

 

US halts AstraZeneca vax production at Baltimore plant

 Coronavirus, COVID 19, Novel Coronavirus, India Fights Corona, Fight Against Corona, Corona Virus Updates ,Coronavirus Epidemic, Coronavirus Pandemic, Corona virus threat, Corona Outbreak, Covaxin, Covishield, Covid-19 Vaccine, COVID-19 Vaccination, COVID Vaccination, Corona virus threat, Coronavirus Vaccine, AstraZeneca vax, AstraZeneca

Web Admin

Web Admin

5 Dariya News

New York , 04 Apr 2021

A plant in the US which ruined 15 million potential doses of Johnson and Johnson's Covid-19 vaccine has been asked to stop producing doses for AstraZeneca, the media reported.The facility at Baltimore, Emergent Biosolutions, was earlier picked as a manufacturing partner for both AstraZeneca and Johnson and Johnson.In a statement on Saturday, Johnson and Johnson said it was "assuming full responsibility" regarding the manufacturing of drug substance for its Covid-19 vaccine at the Emergent BioSolutions.The development, first reported by The New York Times, could be a setback for AstraZeneca which is yet to receive approval for its Covid-19 vaccines in the US.According to a report in The New York Times last week, a mix-up at the Baltimore manufacturing plant ruined 15 million potential doses of the Johnson and Johnson Covid-19 vaccine.Johnson and Johnson then said that the "quality control process identified one batch of drug substance that did not meet quality standards at Emergent Biosolutions, a site not yet authorised to manufacture drug substance for our Covid-19 vaccine".After taking charge of manufacturing its drug substance at the facility, the company said it was adding dedicated leaders for operations and quality, and significantly increasing the number of manufacturing, quality and technical operations personnel to work with the specialists already at Emergent.Johnson and Johnson said that all of its Covid-19 vaccine doses distributed to date have met rigorous regulatory quality standards.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Fight Against Corona , Corona Virus Updates , Coronavirus Epidemic , Coronavirus Pandemic , Corona virus threat , Corona Outbreak , Covaxin , Covishield , Covid-19 Vaccine , COVID-19 Vaccination , COVID Vaccination , Corona virus threat , Coronavirus Vaccine , AstraZeneca vax , AstraZeneca

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD